DrugPatentWatch Database Preview
AVELOX Drug Profile
When do Avelox patents expire, and when can generic versions of Avelox launch?
Avelox is a drug marketed by Bayer Hlthcare and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has forty-nine patent family members in thirty-nine countries.
The generic ingredient in AVELOX is moxifloxacin hydrochloride. There are eighteen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the moxifloxacin hydrochloride profile page.
Summary for AVELOX
International Patents: | 49 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 2 |
Suppliers / Packagers: | 6 |
Bulk Api Vendors: | 89 |
Clinical Trials: | 39 |
Patent Applications: | 836 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for AVELOX |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for AVELOX |
DailyMed Link: | AVELOX at DailyMed |

Pharmacology for AVELOX
Drug Class | Quinolone Antimicrobial |
Synonyms for AVELOX
(4aS-cis)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolol(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride |
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride |
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride |
1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4 |
1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid HCl |
1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride |
1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride |
1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride |
1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride |
186826-86-8 |
186826-86-8 151096-09-2(base) |
192927-63-2 |
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-, monohydrochloride |
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-,monohydrochloride |
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid hydrochloride |
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid hydrochloride |
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride |
7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride |
826M868 |
AB0016427 |
AC-1275 |
AC1L2R0P |
ACT02692 |
Actira |
AK-72941 |
AKOS015920132 |
AKOS016015225 |
AN-15101 |
API0005432 |
AT-15459 |
Avalox |
Avelox (TN) |
AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER |
BAY 12-0839 |
Bay-12-8039 |
BAY-128039 |
BAY12-8039 |
BC205778 |
BCP0726000173 |
BCP9000963 |
BR-72941 |
C-22335 |
C21H24FN3O4.HCl |
C21H25ClFN3O4 |
C53598599T |
CAS-186826-86-8 |
CC-31016 |
cc-97 |
CCG-100924 |
CHEBI:7008 |
CHEMBL1200735 |
CM0156 |
CPD000469185 |
CS-1063 |
D00874 |
DSSTox_CID_25921 |
DSSTox_GSID_45921 |
DSSTox_RID_81224 |
DTXSID4045921 |
FT-0080006 |
FT-0082441 |
HE320859 |
HY-66011 |
IDIIJJHBXUESQI-DFIJPDEKSA-N |
Izilox |
KB-78950 |
KS-1181 |
LS-173737 |
M2479 |
MFCD00949117 |
MFLX |
MLS001401368 |
MolPort-005-934-227 |
Moxifloxacin (Hydrochloride) |
Moxifloxacin for peak identification, European Pharmacopoeia (EP) Reference Standard |
Moxifloxacin HCl |
Moxifloxacin hydrochloride |
Moxifloxacin hydrochloride (JAN/USAN) |
Moxifloxacin hydrochloride [USAN:USP] |
Moxifloxacin hydrochloride [USAN] |
Moxifloxacin hydrochloride, >=98% (HPLC) |
Moxifloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard |
Moxifloxacin Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur |
Moxifloxacin hydrochloride, United States Pharmacopeia (USP) Reference Standard |
Moxifloxacin hydrochloride, VETRANAL(TM), analytical standard |
Moxifloxacine hydrochloride |
Moxivig |
NC00174 |
NCGC00095130-01 |
NCGC00271749-02 |
O381 |
Octegra |
RL02375 |
S-3681 |
S1465 |
SAM001246654 |
SCHEMBL37285 |
SMR000469185 |
ST2413518 |
Tox21_111439 |
Tox21_111439_1 |
UNII-C53598599T |
Vegamox |
Vigamox |
Vigamox (TN) |
US Patents and Regulatory Information for AVELOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | AVELOX | moxifloxacin hydrochloride | TABLET;ORAL | 021085-001 | Dec 10, 1999 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
Bayer Hlthcare | AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER | moxifloxacin hydrochloride | SOLUTION;INTRAVENOUS | 021277-001 | Nov 30, 2001 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
Bayer Hlthcare | AVELOX | moxifloxacin hydrochloride | TABLET;ORAL | 021085-001 | Dec 10, 1999 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
Bayer Hlthcare | AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER | moxifloxacin hydrochloride | SOLUTION;INTRAVENOUS | 021277-001 | Nov 30, 2001 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for AVELOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Hlthcare | AVELOX | moxifloxacin hydrochloride | TABLET;ORAL | 021085-001 | Dec 10, 1999 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Bayer Hlthcare | AVELOX | moxifloxacin hydrochloride | TABLET;ORAL | 021085-001 | Dec 10, 1999 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Bayer Hlthcare | AVELOX | moxifloxacin hydrochloride | TABLET;ORAL | 021085-001 | Dec 10, 1999 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for AVELOX
Drugname | Dosage | Strength | RLD | Date |
---|---|---|---|---|
➤ Subscribe | Injection | 1.6 mg/mL | ➤ Subscribe | ➤ Try a Free Trial |
International Patents for AVELOX
Country | Document Number | Estimated Expiration |
---|---|---|
Brazil | 9915208 | ➤ Try a Free Trial |
Slovenia | 1128831 | ➤ Try a Free Trial |
Ukraine | 72483 | ➤ Try a Free Trial |
Bulgaria | 64974 | ➤ Try a Free Trial |
Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for AVELOX
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
2004012 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: MOXIFLOXACINI HYDROCHLORIDUM (1-CIKLOPROPIL-6-FLUOR-__ 1,4-DIHIDRO-8-METOKSI-7-[(4AS, 7AS)-OKTAHIDRO-6H-PIROLO[3,4-B]PIRIDIN_-6-IL]-4-OKSO-3-CHINOLINKARBOKSIRûGðTIES HIDROCHLORIDAS) |
2004012,C0780390 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: MOXIFLOXACINI HYDROCHLORIDUM (1-CIKLOPROPIL-6-FLUOR-1,4-DIHIDRO-8-METOKSI-7-((4AS, 7AS)-OKTAHIDRO-6H-PIROLO(3,4-B)PIRIDIN-6-IL)-4-OKSO-3-CHINOLINKARBOKSIRUGSTIES HIDROCHLORIDAS); REGISTRATION NO/DATE: 04/8383/3 20040309 |
01C/030 | Belgium | ➤ Try a Free Trial | PRODUCT NAME: MOXIFLOXACINE CHLORHYDRATE (CORRESPONDANT A MOXIFLOXACINE); NATL. REGISTRATION NO/DATE: 187 IS 328 F 3 20010507; FIRST REGISTRATION: DE 45263.00.00 19990621 |
00111 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: MOXIFLOXACINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER MOXIFLOXACINEHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 28118 RVG 28119 20021017; FIRST REGISTRATION: DE 45263.00.00 19990621 |
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |